BRCA Mutations Treatment Market Outlook:
BRCA Mutations Treatment Market size was over USD 4.85 million in 2025 and is anticipated to cross USD 8.52 million by 2035, witnessing more than 5.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of BRCA mutations treatment is assessed at USD 5.1 million.
The increasing prevalence of cancer patients globally will exponentially propel the growth of the BRCA mutations treatment market by the end of 2037. According to WHO, 20 million new examples of cancer and 9.7 million deaths from the disease are assumed for 2022. 53.5 million people were assumed to still live their lives five years after receiving a cancer diagnosis. One in five people will have cancer at some point in their lives; one in nine men and one in twelve women will die from the sickness.
